semaglutide and liver function Can Cause Damage? Safety Evidence Explained Summary of semaglutide clinical use.

Patients should not advance to higher doses if experiencing persistent nausea or vomiting

District Judge Gene Prater

The medication slows gastric emptying, which can reduce intestinal motility and lead to difficulty with bowel movements within the first few weeks of therapy

The development of nausea and vomiting, encountered in every GLP-1 development program, often limited dose escalation and likely delayed introduction of GLP-1R agonists, utilized at higher doses, with greater efficacy

Instead, the medication is introduced gradually to allow your body to adjust and to minimize side effects [21][22]

Aliabadi is an expert OB/GYN who is knowledgeable in all aspects of womens health and well-being